Published in
Elsevier, European Journal of Cancer, (181), p. 135-144, 2023
DOI: 10.1016/j.ejca.2022.12.014
Links
Tools
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)
Journal article published in 2023 by
Masato Ozaka 
,
Kohei Nakachi,
Satoshi Kobayashi ,
Akihiro Ohba ,
Hiroshi Imaoka,
Takeshi Terashima,
Hiroshi Ishii ,
Junki Mizusawa,
Hiroshi Katayama,
Tomoko Kataoka ,
Takuji Okusaka,
Masafumi Ikeda ,
Naoki Sasahira ,
Haruo Miwa,
Eishiro Mizukoshi
and other authors.
,
Kohei Nakachi,
Satoshi Kobayashi ,
Akihiro Ohba ,
Hiroshi Imaoka,
Takeshi Terashima,
Hiroshi Ishii ,
Junki Mizusawa,
Hiroshi Katayama,
Tomoko Kataoka ,
Takuji Okusaka,
Masafumi Ikeda ,
Naoki Sasahira ,
Haruo Miwa,
Eishiro Mizukoshi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 